January 1, 2015 |
Dow Chemical Co. has quietly settled lawsuits brought by the estates of two chemists who died of brain cancer after working at the former Rohm & Haas Co. research labs in Montgomery County. The company, which purchased Rohm & Haas in 2009, agreed to pay a total of $950,000 - $475,000 in each case, according to records filed in Common Pleas Court in Philadelphia. The settlements bring to a close nearly a decade of litigation, during which plaintiffs' attorneys alleged that Rohm & Haas did not provide lab employees with sufficient protection against toxic chemicals and did not adequately warn them about the rising number of brain cancers.
October 30, 2007 |
Shares of small-business credit card issuer Advanta Corp. tumbled again yesterday amid signs that credit conditions were worsening. The Spring House company's widely held class B shares have dropped 28 percent since it released disappointing earnings Thursday and are off 46 percent from a recent peak of $29.80 on Oct. 5. They closed yesterday at $16.09, down 71 cents, or 4.2 percent, on the Nasdaq. On Friday, the investment bank Friedman, Billings, Ramsey & Co. Inc. slashed its price target on Advanta shares by half, to $17.50 from $35, after the company fell 5 cents short of expected earnings per share of 55 cents.
December 19, 2002 |
Rohm & Haas Co., the Philadelphia chemical maker, is studying what appears to be an elevated rate of brain cancer among former employees at its Spring House facility. In a letter to the former employees, the company wrote that it knows of 10 cases of brain cancer among the 6,000 who have worked at the Montgomery County facility in the 40 years it has been open. Based on what they acknowledge is a rough calculation, company officials said that cancer rate was about twice that of the general U.S. population.
November 10, 2009 |
Pfizer Inc., which bought rival Wyeth last month, said yesterday that it would move "a number of functions" from Wyeth's Collegeville, Montgomery County, location as Pfizer consolidated research and development at five "hub" sites. Separately yesterday, Johnson & Johnson told Pennsylvania state officials that it would lay off 174 people at its Spring House facility as it pushed forward with 8,000 global job cuts the company announced last week. Pfizer would not immediately say how many jobs would be eliminated at Collegeville - Wyeth's long-term pharmaceutical headquarters - where it employs 3,600.
April 20, 2007 |
Johnson & Johnson said yesterday that it has begun construction of a $181 million building at its Spring House complex that will add 120 jobs and become the East Coast "hub" for its early-stage drug-discovery research and development. The 150,000-square-foot building will add laboratories, clinical development and office space. It is scheduled to be completed in 2009. Johnson & Johnson Pharmaceutical Research & Development L.L.C. now employs 680 in Spring House, where the company said prescription medicines, including Topamax, Ultram and Ultracet, were developed.
April 21, 2012 |
Joseph Snizavich started having seizures and stroke-like symptoms in July 2005, and within three years, the longtime pipe fitter was dead of brain cancer. His widow blamed the illness on his exposure to chemicals at a Rohm & Haas research facility, where a study found that employees had developed brain cancer at twice the expected rate. But proving a connection between the chemicals and any one particular brain cancer could be difficult, if a judge's ruling this week is any indication.
April 30, 1992 |
About 10 acres at the Rohm & Haas Research Laboratories in Spring House are being converted to a natural habitat. This is the third year of an ongoing project, and every year, there's a tree-planting day for employees; Mike Freeman was among those involved Saturday.
July 13, 1989 |
IT'S A SPECIAL DAY for Little Leaguers on the grounds of the Rohm & Haas Research Labs in Spring House, when ex-Phillies relief star Tug McGraw holds a baseball clinic. After running the youngsters through some drills Saturday, McGraw fielded questions.
January 5, 2012 |
Giant Food Stores announced Thursday it will acquire 16 Genuardi's Family Markets across the Philadelphia area in a $106 million deal that will significantly alter the supermarket landscape in the region by giving surging Giant an even greater profile in the highly competitive suburbs. The transaction, expected to close over the next six months, would transfer ownership of the stores from Safeway Inc., and convert them all to Giant, whose operations are headquartered in Carlisle, Pa. The stores affected are on York Road in Jamison, Eagle Road in Newtown, Flowers Mill Road in Langhorne, County Line Road in Chalfont, Boot Road in West Chester, East Baltimore Pike in East Marlborough, East Lancaster Avenue in St. Davids, Baltimore Pike in Springfield, Wynnewood Road in Wynnewood, Bethlehem Pike in Flourtown, Huntingdon Pike in Huntingdon Valley, Bethlehem Pike in Spring House, South Henderson Road in King of Prussia, Norristown Road in Maple Glen, Susquehanna Road in Roslyn, and Sumneytown Pike in North Wales.